Sales for the quarter ended at MNOK 57.9 (MNOK 48.9), an increase of 18.5 %. Operating profit (EBIT) ended at MNOK 9.9 (MNOK 7.2), up 36.7 %. There was a strong development in sales in the US with an increase in sales with 50 %. Currency neutral growth in the US was 19 %. VeriQC was cleared for sale in China during the quarter. Medtronic is not renewing the distribution agreement with Medistim Norge AS.